DUBLIN–(BUSINESS WIRE)–The “Bone Metabolism Assays – Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.
This report provides an overview of Bone Metabolism Assays currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products.
Scope
- Extensive coverage of the Bone Metabolism Assays under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bone Metabolism Assays and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Bone Metabolism Assays under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered
1 Table of Contents
2 Introduction
2.1 Bone Metabolism Assays Overview
3 Products under Development
3.1 Bone Metabolism Assays – Pipeline Products by Stage of Development
3.2 Bone Metabolism Assays – Pipeline Products by Segment
3.3 Bone Metabolism Assays – Pipeline Products by Territory
3.4 Bone Metabolism Assays – Pipeline Products by Regulatory Path
3.5 Bone Metabolism Assays – Pipeline Products by Estimated Approval Date
4 Bone Metabolism Assays – Pipeline Products under Development by Companies
4.1 Bone Metabolism Assays Companies – Pipeline Products by Stage of Development
4.2 Bone Metabolism Assays – Pipeline Products by Stage of Development
5 Bone Metabolism Assays Companies and Product Overview
5.1 Alere Inc
5.2 AMS Diagnostics LLC
5.3 Beckman Coulter Inc
5.4 Carolina Liquid Chemistries Corp
5.5 DiaSorin SpA
5.6 Immunodiagnostic Systems Holdings plc
5.7 Novartis AG
5.8 OJ-Bio Ltd (Inactive)
5.9 Shenzhen Mindray Bio-Medical Electronics Co Ltd
5.10 Siemens Healthineers AG
5.11 Tosoh Bioscience Inc
6 Bone Metabolism Assays – Recent Developments
6.1 Mar 07, 2019: Mindray signs patient safety movement’s open data pledge & becomes 90th company to join to improve patient safety
6.2 Dec 04, 2018: Mindray international exchange program on hematology: linking medical expertise across borders
For more information about this report visit https://www.researchandmarkets.com/r/fet3gh
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900